| |||||||||||||||||||||||||||||||||||||||||
Deer tick virus is related to Powassan virus, a tickborne encephalitis virus. A 62-year-old man presented with a meningoencephalitis syndrome and eventually died. Analyses of tissue samples obtained during surgery and at autopsy revealed a widespread necrotizing meningoencephalitis. Nucleic acid was extracted from formalin-fixed tissue, and the presence of deer tick virus was verified on a flavivirus-specific polymerase-chain-reaction (PCR) assay, followed by sequence confirmation. Immunohistochemical analysis with antisera specific for deer tick virus identified numerous immunoreactive neurons, with prominent involvement of large neurons in the brain stem, cerebellum, basal ganglia, thalamus, and spinal cord. This case demonstrates that deer tick virus can be a cause of fatal encephalitis.
Several members of the tickborne encephalitis group of flaviviruses, including tickborne encephalitis virus and Powassan virus, cause encephalitis in humans and animals, with tickborne encephalitis virus causing the most serious outbreaks. These viruses are closely related antigenically and are found predominantly in the northern hemisphere. In Europe, tickborne encephalitis occurs mainly in eastern and central regions and affects approximately 50 to 199 persons per 100,000 inhabitants annually.5 The seroprevalence of antibodies to Powassan virus is estimated to be 0.5 to 4.0% in areas in which the disease is endemic.6
Infection with tickborne encephalitis virus can be mild or asymptomatic, or it can result in meningitis and encephalitis. Powassan virus can be pathogenic in human beings and can cause severe encephalitis with a fatality rate of up to 60% and long-term neurologic sequelae in survivors.7 In contrast, Central European encephalitis that is caused by tick bites typically produces mild or silent infection. Other disease-causing flaviviruses include West Nile virus, St. Louis encephalitis virus, dengue virus, and yellow fever virus.8 These viruses are transmitted by mosquitoes and cause a spectrum of diseases including meningitis, encephalitis, dengue fever, and yellow fever.
In certain locations of the northeastern and north central United States, the prevalence of deer tick virus in adult deer ticks is high,9,10 but human infection has not been reported previously. This could indicate that the virus does not easily infect humans or that it is not particularly pathogenic. Diagnostic testing for Powassan virus is not routinely performed for patients with symptoms of encephalitis. Human incidence may thus be currently underestimated.
Case Report
In late spring, a 62-year-old man was admitted to a local New York State hospital with a 4-day history of fatigue, fever, bilateral maculopapular palmar rash, and an onset of diplopia, dysarthria, and weakness in the right arm and leg. He was a native of New York State and had no history of recent travel. He owned horses and spent time outdoors in a wooded area. Reports of Lyme disease were common in his county of residence, indicating tick activity in the area. His medical history included chronic lymphocytic leukemia–small lymphocytic lymphoma (CLL–SLL), which had been diagnosed 4 years earlier and had initially been treated with fludarabine. He was not taking corticosteroids. On admission, he was given nonsteroidal antiinflammatory medication and an oral antibiotic (amoxicillin–clavulanate), which had been prescribed by his primary care physician for a recent exacerbation of chronic sinusitis that had been recurrent for more than a year. His baseline white-cell count was 15,000 cells per cubic millimeter and had increased to 70,000 cells per cubic millimeter during the past 6 to 8 months. He was started on broad-spectrum antibiotics and acyclovir (700 mg administered intravenously every 8 hours) for presumed infection of the central nervous system. The differential diagnosis included cerebral ischemia, possibly related to leukostasis, infection (viral, bacterial, or fungal), and lymphoma.
Initial laboratory results were notable for a markedly elevated peripheral-blood white-cell count (144,200 cells per cubic millimeter) and cerebrospinal fluid with normal glucose, minimally elevated protein, no white cells, and a negative Gram's stain (Table 1). The erythrocyte sedimentation rate was 4, blood cultures were sterile, and antibody titers were negative for Borrelia burgdorferi and Anaplasma phagocytophilum. The neurologic symptoms progressed, and after 2 days he was transferred to another hospital. At the time of transfer, the peripheral-blood white-cell count was 174,800 per cubic millimeter (with 4% neutrophils and 94% lymphocytes) (Table 1).
|
Magnetic resonance imaging (MRI) performed after transfer (hospital day 1) revealed abnormal T2-weighted and fluid-attenuated inversion recovery (FLAIR) images, with hyperintensities most prominent in the superior cerebellum, left pons, and bilateral basal ganglia (Figure 1A, 1B, and 1C). An axial diffusion-weighted image and apparent-diffusion-coefficient sequences revealed restricted diffusion in the superior cerebellum, suggesting an ischemic process (Figure 1D). The patient remained febrile (maximum temperature, 104.5°F [40.3°C]), and antimicrobial coverage was broadened to include an antifungal agent. His neurologic function deteriorated, which necessitated intubation, and his function did not improve despite maximal medical therapy.
|
MRI of the brain on hospital day 7 revealed progression of signal abnormalities, new lesions in the right thalamus and bilateral cerebral hemispheres, and persistent hydrocephalus (Fig. 2 in the Supplementary Appendix). By hospital day 11, there was no improvement in his status. Life support was withdrawn, and he died 17 days after the onset of symptoms. An autopsy was performed.
Methods
Clinical Specimens
A surgical biopsy of the cerebellum was fixed in formalin and embedded in paraffin. After autopsy, the brain was formalin-fixed for 2 weeks, and standard tissue blocks were paraffin-embedded. Unembedded, formalin-fixed brain tissue from the midbrain, cerebellum, pons, and spinal cord was submitted for PCR testing. (For details on viruses and control samples that were used, see the Methods section in the Supplementary Appendix.)
Reverse-Transcriptase–PCR and Sequence Analysis
Nucleic acid was extracted from formalin-fixed tissue with the use of the WaxFree DNA extraction kit (TrimGen). This kit coextracts RNA. Ten microliters of extracted nucleic acid was reverse-transcribed to complementary DNA (cDNA) with the use of the iScript cDNA synthesis kit (Bio-Rad). Heminested reverse-transcriptase PCR (RT-PCR) for the detection of flavivirus with the use of universal primers was performed as described previously.11,12 (In the Supplementary Appendix, additional information on the PCR primers is listed in Table A, and details regarding the PCR methods, sequence, and histologic and immunohistochemical analyses are listed in the Methods section.)
Results
The general autopsy revealed diffuse lymphadenopathy and splenomegaly and infiltration of liver and kidney by CLL–SLL. The brain weight was 1810 g (normal range in adults, 1300 to 1350), consistent with marked edema. On sectioning, there was marked softening and grayish discoloration throughout the brain stem and cerebellum.
Histologic examination of the brain revealed widespread meningopolioencephalitis and meningopoliomyelitis; there was no evidence of infiltration by CLL–SLL. A mild meningeal lymphocytic infiltrate persisted, and dense perivascular infiltrates were still identified in the parenchyma (Fig. 3C to 3K in the Supplementary Appendix). Throughout the brain, multinodular to patchy mononuclear infiltrates and confluent areas of necrosis were identified, along with microglial nodules and neuronophagia. This was most accentuated in large motor neurons of the brain stem (including cranial nerve nuclei), spinal anterior horns, cerebellum, basal ganglia, and thalamus (Figure 2, and Fig. 3 in the Supplementary Appendix). Microglia–macrophage infiltration was greatest in gray-matter regions but also involved white-matter tracts to a lesser degree (Fig. 3A in the Supplementary Appendix).
|
On the extracted nucleic acid from the formalin-fixed brain tissue, the following analyses were performed: a PCR panel including real-time PCR assays for the detection of herpes simplex viruses 1 and 2, Epstein–Barr virus, cytomegalovirus, human herpesvirus type 6, varicella–zoster virus, and adenovirus; real-time RT-PCR assays for the detection of West Nile virus and eastern equine encephalitis virus; a real-time PCR assay using a cDNA template for the detection of enterovirus; a group-specific RT-PCR assay for the detection of alphaviruses13; and conventional PCR assays using a cDNA template for the detection of St. Louis encephalitis, California serogroup, and Cache Valley viruses. PCR assays for the detection of borrelia species, including B. burgdorferi, and of A. phagocytophilum were performed on DNA extracts from the cerebellum and spinal cord. All results were negative. A group-specific RT-PCR assay for the detection of flaviviruses gave PCR products of the expected size for both the first-round PCR and the nested PCR.11 The PCR products of approximately 250 bp and 220 bp were purified from the gel and sequenced. A search with the use of the nucleotide Basic Local Alignment Search Tool (BLAST) algorithm posted on the Web site of the National Center for Biotechnology Information identified a 220-bp sequence sharing 97% of the sequence of deer tick virus strains CTB30 (accession number, AF311056.1), and IPS001 (accession number, AF310947.1) and Powassan virus strain R59266 (accession number, AF310948.1). To confirm the lineage of the virus, sequencing was performed with the use of previously published and newly designed primer sets from the envelope coding region, NS5, and sequences in the 3' untranslated region1,4 (Table A in the Supplementary Appendix).
With a total of 23 primer sets used, two regions of the virus were sequenced: 2748 bp, spanning part of the RNA polymerase coding sequence and the 3' untranslated region of the virus, and 1180 bp of the envelope coding sequence. Phylogenetic analyses of these fragments indicated that the virus, named DT-NY-07, was most closely related to the deer tick virus (Figure 3).14,15,16
|
|
Strains of Powassan virus lineages I and II are distinct and are maintained in separate enzootic cycles because of differences in transmission vectors and geographic distribution. Lineage I strains are transmitted by ticks and have been reported in North America (mainly in New York State and Canada) and in eastern Russia, whereas lineage II strains have been isolated in the Atlantic Coast of the United States and in Wisconsin.4 Lineage I strains appear to be associated with I. cookei and groundhogs (Marmota monax), whereas lineage II strains are associated with deer ticks and white-footed mice (Peromyscus leucopus).7 In addition, lineage II strains have not previously been associated with human disease, whereas a number of infections in humans associated with lineage I strains have been documented.17,18,19,20,21 From these reports, it appears that lineage I Powassan encephalitis is characterized by respiratory distress, fever, vomiting, convulsions, and occasionally paralysis.17,19 Studies in the northern Ontario region of Canada show an antibody prevalence rate of as much as 3.2%, indicating that infection does not always cause severe disease.22 In a phylogenetic study of Powassan-related viruses of North America, a lineage II strain (ON97) was reportedly isolated from human brain tissue.2 However, no other information regarding the case was provided.
Confirmation of infection with a lineage I strain of Powassan virus has been made principally by serologic methods. Because of serologic cross-reactivity, these methods do not necessarily distinguish lineage I from lineage II strains. Neutralization assays are required for confirmation; molecular detection and sequence determination, as performed in our investigation, allowed for definitive classification of the virus.
In this study, we detected deer tick virus by both molecular and immunohistochemical methods in the central nervous system of a patient with encephalitis. The neurotropism seen in this case, with involvement of both gray and white matter, matches the pattern of central nervous system infection for arboviruses, which may be highly neuroinvasive.23
The patient was known to have frequented wooded areas, although no specific contact with ticks had been reported. He presented in late spring, which suggested that transmission was probably from nymphal deer ticks, which are most active during spring and summer months. In addition, since nymphal deer ticks are small in size (1.5 mm in diameter), it is not uncommon for their bites to remain undetected. It is possible that the patient's underlying condition (CLL–SLL) predisposed him to particularly serious disease. Reports of elderly and immunocompromised patients being at a greater risk for severe encephalitis caused by West Nile virus are well documented.24,25
Our immunohistochemical studies with newly generated deer tick virus antibodies demonstrated prominent labeling of neuronal-cell bodies and their processes; a focus of apparent oligodendroglial infection was also identified (Figure 4). In addition, some neurons contained rounded granular-to-tubular profiles. A segmental distribution of immunolabeling was evident in the hippocampus, as was seen in cerebellum infected by central European tickborne encephalitis virus, as described previously.26 The parenchymal lymphocytic infiltrates in this case and in previous pathological studies of tickborne encephalitis virus26,27 were predominantly CD8+ cytotoxic T cells, which were also seen in close apposition to surviving neurons, further indicating that immunologic mechanisms may have contributed to nerve-cell destruction in tickborne encephalitides.
Diagnostic testing for Powassan virus is not routinely performed in patients with encephalitis. More extensive testing for arboviruses, including Powassan virus, might reveal that arboviral infections are more widespread than previously reported. For Powassan virus, testing is especially important during the summer months and in regions where infected ticks are prevalent. Deer ticks transmit several tickborne diseases, including Lyme disease, human babesiosis, and human granulocytic anaplasmosis.28 This report of deer tick virus resulting in a fatal case of encephalitis emphasizes the significance of deer ticks in transmitting a variety of infections. There are limited data on the prevalence of infection with deer tick virus among adult deer ticks, although a rate of 0.6 to 1.3% in limited geographic areas in the United States has been reported.9 Because no specific antiviral therapy is available for Powassan infection, the best strategy remains prevention (i.e., avoidance of contact with the arthropod vector). Studies to elucidate the prevalence and relative pathogenic features of Powassan lineages I and II are warranted.
Supported in part by the National Institute of Allergy and Infectious Diseases, by a contract (N01-A1-25490) and a grant (AI067380) from the National Institutes of Health, and by a cooperative agreement (U01-CI000311) with the Centers for Disease Control and Prevention (CDC).
No potential conflict of interest relevant to this article was reported.
The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the CDC.
We thank Dr. Laura Kramer and the Arbovirus Laboratory staff at Wadsworth Center for cultures of Powassan virus, Bryce Chackerian for assistance with mouse immunization, Dr. Gino Battaliogli for assistance in nucleic acid extraction from formalin-fixed tissues, the Bacteriology Laboratory at the Wadsworth Center for performing PCR assays on B. burgdorferi and A. phagocytophilum, and the Molecular Genetics Core at the Wadsworth Center for performing the sequencing reactions.
Source Information
From the Wadsworth Center, New York State Department of Health (N.P.T., H.W., M.D., R.H.), and the Department of Biomedical Sciences, School of Public Health, University at Albany (N.P.T.) — both in Albany; the Department of Pathology, University of New Mexico School of Medicine, Albuquerque (G.D.E.); and the Departments of Neurology (E.J.G.) and Pathology and Cell Biology (P.L.F.), Columbia University, and New York Presbyterian Hospital (E.J.G., P.L.F.) — both in New York.
Address reprint requests to Dr. Tavakoli at the Empire State Plaza, P.O. Box 509, Albany, NY 12201, or at norma.tavakoli{at}wadsworth.org.
References
| |||||||||||||||||||||||||||||||||||||||||
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |